Page last updated: 2024-10-23

azathioprine and Dominant Hereditary Sensory Neuropathy, Type III

azathioprine has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hokkanen, E1

Other Studies

1 other study available for azathioprine and Dominant Hereditary Sensory Neuropathy, Type III

ArticleYear
Myasthenia gravis. A clinical analysis of the total material from Finland with special reference to endocrinological and neurological disorders.
    Annals of clinical research, 1969, Volume: 1, Issue:2

    Topics: Age Factors; Ambenonium Chloride; Azathioprine; Cortisone; Diabetes Complications; Disability Evalua

1969